Kagan Legal GroupKagan Legal GroupKagan Legal GroupKagan Legal Group
  • Home
  • About
  • Attorneys
    • Andrew Kagan Esquire, LHRM
    • Elizabeth P. Kagan Esquire, BSN, LHRM
    • Gabriel Perez
  • Defective Drugs
    • Abilify
    • Aciphex
    • Actos
    • Accutane
    • Benicar
    • Cipro, Levaquin, & Avelox
    • Elmiron
    • Fluoroquinolone Aortic Aneurysms
    • Invokana
    • Nexium
    • Paxil
    • Taxotere
    • Viagra
    • Zofran
    • Zostavax
  • Defective Products
    • Bair Hugger Blanket
    • Hernia Mesh Lawsuit
    • IVC Filter
    • Metal On Metal Hips
    • Mirena
    • Pelvic Mesh
    • Power Morcellator
    • Roundup
    • Talcum Powder
  • Government Taking
  • Contact Us

Zofran Claims

Did yourself or someone you know take Zofran, also known as the generic drug Ondansetron, to prevent nausea and vomiting during pregnancy?

Zofran Birth Defect Claims

Take Action Now

Zofran (ondansetron) is an anti-emetic, commonly used to treat nausea and vomiting in post-surgical and cancer patients suffering the side effects of chemotherapy and radiotherapy. Drug manufacturers GlaxoSmithKline soon discovered another target market- nearly 80 percent of pregnant women experience nausea and vomiting during pregnancy (NVP). The most serious form of NVP, called hyperemesis gravid arum, can lead to malnutrition and dehydration –dangerous for both the mother and the baby. GlaxoSmithKline began recommending the use of Zofran for pregnant women suffering from morning sickness or hyperemesis gravid arum. The use was off-label, meaning that no previous testing had been done and it lacked FDA approval. But that didn’t stop the drug giant from claiming the drug was safe for pregnant woman and their unborn children.

Since the off-label use, numerous birth defects have been reported, including

  • Heart defects
    • Heart murmur
    • Atrial septal defect
    • Ventricular septal defect
  • Cleft palate/cleft lip
  • Kidney defects
    • Hydronephrosis
  • Hypospadia
  • Musculoskeletal defects
    • Craniosynostosis (skull deformities)
  • Fetal growth restriction

Birth defects can be life changing, and permanent. Court documents show GlaxoSmithKline was aware from as early as 1992 that Zofran presented “unreasonable risk of harm” to developing babies as the drug passes through the placenta. Despite this information, the drug maker continued to market the drug to pregnant women.

Schedule Your Free Case Evaluation

Contact The Kagan Legal Group Today

If yourself or a loved one had a child that was born with a defect and took Zofran® while pregnant, take action by contacting the Kagan Legal Group. Fill out the form below, or contact us directly for a FREE case evaluation and you may be eligible for the financial compensation you deserve.

Contact Us

The Kagan Legal Group

Office Address:

295 Palmas Inn Way, Suite 6 Palmanova Plaza
Humacao, Puerto Rico 00791

Phone:

(939) 220-2424

Email

Info@Kaganlegalgroup.com

Copyright 2021 Kagan Legal Group | All Rights Reserved
  • Home
  • About
  • Attorneys
    • Andrew Kagan Esquire, LHRM
    • Elizabeth P. Kagan Esquire, BSN, LHRM
    • Gabriel Perez
  • Defective Drugs
    • Abilify
    • Aciphex
    • Actos
    • Accutane
    • Benicar
    • Cipro, Levaquin, & Avelox
    • Elmiron
    • Fluoroquinolone Aortic Aneurysms
    • Invokana
    • Nexium
    • Paxil
    • Taxotere
    • Viagra
    • Zofran
    • Zostavax
  • Defective Products
    • Bair Hugger Blanket
    • Hernia Mesh Lawsuit
    • IVC Filter
    • Metal On Metal Hips
    • Mirena
    • Pelvic Mesh
    • Power Morcellator
    • Roundup
    • Talcum Powder
  • Government Taking
  • Contact Us
Kagan Legal Group